SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 7th, 2022 • Vor Biopharma Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 7th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 7, 2022, between Vor Biopharma Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 8th, 2022 • Provention Bio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 8th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 7, 2022 (the “Effective Date”), among Provention Bio, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).